Status:
COMPLETED
Using CGM for Evaluating Effects of Food on Glucose Regulation in Healthy Humans
Lead Sponsor:
DoubleGood AB
Collaborating Sponsors:
starScience GmbH
Conditions:
Glycemic Control
Diet, Food and Nutrition
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
The specific goal of this pilot study is to evaluate if it is possible to detect a statistical difference in postprandial glycemia after meals served with and without a drink previously shown to reduc...
Eligibility Criteria
Inclusion
- BMI 25-29.9 kg/m\^2
- HOMA-IR \< 2.5
- Fasting glucose \< 6.1 mmol/L
- Stable weight since 3 months
- Access to iPhone with Bluetooth 4.0 and iOS 13 or later
Exclusion
- Diabetes
- Pharmacological treatment known to interfer with metabolism
- Antibiotics treatment the latest 3 months
- Vegetarian/Vegan diet
- Use of tobacco
- Pregnancy or breast-feeding
Key Trial Info
Start Date :
April 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 26 2021
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04848233
Start Date
April 20 2021
End Date
May 26 2021
Last Update
November 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aventure AB
Lund, Sweden, 223 63